Advanced Cell Technology Inc.
Description Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine. The company is conducting various clinical trials for treating macular degeneration, and has a preclinical development pipeline focused on products for eye diseases, autoimmune and inflammatory diseases, and wound healing. Its intellectual property portfolio includes pluripotent stem cell platforms comprising embryonic stem cell and induced pluripotent stem cell (iPSC) platforms; and other cell therapy research programs, such as opthamology, autoimmune/inflammation, and platelet programs. Advanced Cell Technology, Inc. develops and maintains an intellectual property portfolio, with ownership or licensing of approximately 37 issued patents and approximately 190 patent applications pending in the field of regenerative medicine and stem cell therapy. The company is headquartered in Marlborough, Massachusetts. To view the detailed information, you need to SUBSCRIBE with us. |
 |